Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

itf hellas ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΗ ΕΤΑΙΡΕΙΑ Δ.Τ. itf hellas s.a. Αρεως 103 & Αγίας Τριάδος 36,, 175 62 17562, Π. Φάληρο 210.9373332 - estriol - vag.gel (ΚΟΛΠΙΚΗ ΓΕΛΗ) - 50mcg/g - estriol 50mcg - estriol

Kypros - gresk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

itf hellas a.e. (0000008180) areos 103 and agias triados 36, palaio faliro, 17562 - estriol - vaginal gel - 50mcg/g - estriol (0000050271) 50ug

Hellas - gresk - myHealthbox

bayer ΕΛΛΑΣ ΑΒΕΕ -

Den europeiske union - gresk - EMA (European Medicines Agency)

chiesi farmaceutici s.p.a - pegunigalsidase alfa - fabry disease - Άλλα προϊόντα πεπτικής οδού και μεταβολισμού, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

pierre fabre farmaka ae Μεσογείων 350,, 153 41 153 41, Αγ. Παρασκευή 210.7234582 - serenoa repens lipidosterolic extract - c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΔΙΣΚΙΟ) - 80mg/tab - serenoa repens lipidosterolic extract 80mg - serenoa repens

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

pierre fabre hellas ae (0000003304) Λεωφ. Μεσογείων 350 & Θράκης 64,, 153 41, Αγία Παρασκευή, 153 41 - tretinoin - ΚΡΕΜΑ - 0,05% (w/w) - 0000302794 tretinoin 0.500000 mg - tretinoin

Den europeiske union - gresk - EMA (European Medicines Agency)

taw pharma (ireland) limited - υδροχλωρική κλοπιδογρέλη - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - Αντιθρομβωτικοί παράγοντες - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

ΦΑΡΜΑΖΑΚ ΑΝΩΝΥΜΗ ΦΑΡΜΑΚΕΥΤΙΚΗ ΕΜΠΟΡΙΚΗ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ Δ.Τ. pharmazac ae Ναούσης 31, Βοτανικός,, 104 47 104 47, Αθήνα 210.3418889-97 - lenalidomide - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 2.5mg/cap - lenalidomide 2,5mg - lenalidomide

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

ΦΑΡΜΑΖΑΚ ΑΝΩΝΥΜΗ ΦΑΡΜΑΚΕΥΤΙΚΗ ΕΜΠΟΡΙΚΗ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ Δ.Τ. pharmazac ae Ναούσης 31, Βοτανικός,, 104 47 104 47, Αθήνα 210.3418889-97 - lenalidomide - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 5mg/cap - lenalidomide 5mg - lenalidomide

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

ΦΑΡΜΑΖΑΚ ΑΝΩΝΥΜΗ ΦΑΡΜΑΚΕΥΤΙΚΗ ΕΜΠΟΡΙΚΗ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ Δ.Τ. pharmazac ae Ναούσης 31, Βοτανικός,, 104 47 104 47, Αθήνα 210.3418889-97 - lenalidomide - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 20mg/cap - lenalidomide 20mg - lenalidomide